FDA Adverse Event Malfunction Summary report: N

ARCHITECT CA 19-9XR

MDR report key: 2620257 · Received June 18, 2012

Report

Report Number
1415939-2012-00774
Event Type
Malfunction
Date Received
June 18, 2012
Date of Event
May 9, 2012
Report Date
May 16, 2012
Manufacturer
ABBOTT LABORATORIES
Product Code
NIG
PMA / PMN Number
K052000
Removal / Correction Number
1415939-05/30/12-002-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION OF THE ISSUE REVEALED THAT THE CONJUGATE COMPONENT OF THE ARCHITECT CA19-9XR AFFECTED REAGENT LOTS CONTRIBUTED TO ELEVATED CA19-9XR PATIENT SAMPLE CONCENTRATIONS. ALL AFFECTED LOTS SHARE THE SAME CONJUGATE COMPONENT. ABBOTT ISSUED A PRODUCT RECALL FOR THE SIX AFFECTED LOTS (08851M500, 08849M500, 10122M500, 08852M500, 08853M500, 10040M500) OF THE ARCHITECT CA19-9XR REAGENT, INSTRUCTING CUSTOMERS TO DISCONTINUE USE AND DESTROY ANY REMAINING INVENTORY OF THE AFFECTED LOTS.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED FALSELY ELEVATED CA19-9 RESULTS WHEN ARCHITECT CA19-9 XR LOT 10040M500 WAS IN USE. THE CUSTOMER PROVIDED AN EXAMPLE OF ELEVATED RESULTS IN U/ML FOR SID (B)(4): 50.89 AND 45.66. REPEAT TESTING WITH REAGENT LOT 12343M500 GENERATED A RESULT OF 14.87. THE CUSTOMER STATED CONTROLS WERE ACCEPTABLE AND NO ARCHITECT ERRORS WERE PRODUCED WHEN ELEVATED RESULTS WERE GENERATED. TROUBLESHOOTING OF THE ISSUE WAS DONE BY PERFORMING CHECKS OF THE ARCHITECT, HOWEVER, THE ISSUE WAS RESOLVED WITH A DIFFERENT LOT OF REAGENT. THE FALSELY ELEVATED RESULTS WERE NOT REPORTED OUT THE LAB, THEREFORE, THERE WAS NO IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT CA 19-9XR NIG ABBOTT LABORATORIES 10040M500

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I1000SR, LIST # 3M74-02, SN (B)(4)